KTTA - Financial Reports List - Pasithea Therapeutics Corp. - IntrinsicAlpha

Pasithea Therapeutics Corp. KTTA

Healthcare - Biotechnology - NASDAQ - US

$ 1.565

3.62 %

$ 4.23 M

Market Cap

-0.11

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	0.00%	37.05%	36.69%
Annual Report	FY	10-K	2024-12-31	0.00%	-87012.40%	-89077.30%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	16.96%	20.71%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	-2.74%	-3.04%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	98.60%	-25.78%
Quarterly Report	Q4	8-K	2023-12-31	305.59%	-29.36%	-1.34%
Annual Report	FY	10-K	2023-12-31	0.00%	-22.25%	-7.85%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	21.23%	1.72%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	-107.34%	-24.30%
Quarterly Report	Q1	8-K	2023-03-31	0.00%	-665316.08%	-33.60%

1